| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |